4//SEC Filing
Fowler Wyche 4
Accession 0001209191-17-065438
CIK 0001107421other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:36 PM ET
Size
8.7 KB
Accession
0001209191-17-065438
Insider Transaction Report
Form 4
Fowler Wyche
Director
Transactions
- Tax Payment
Common Stock
2017-12-11$4.20/sh−15,800$66,360→ 146,070 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-11−20,000→ 0 totalExercise: $2.73Exp: 2017-12-12→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2017-12-11$2.73/sh+20,000$54,600→ 161,870 total
Footnotes (2)
- [F1]Represents 13,000 shares withheld to pay exercise price and 2,800 shares withheld to pay tax withholding obligations.
- [F2]6,667 shares vested on each of 12/12/08 and 12/12/09; 6,666 shares vested on 12/12/10.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001301268
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:36 PM ET
- Size
- 8.7 KB